Nabriva Therapeutics Legacy plc

CIK 1703287 · other company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Nabriva Therapeutics Legacy plc.

Recent SEC filings

FiledFormAccession number
Jul 21, 201740001179110-17-010624
Jul 21, 20178-K0001104659-17-046316
Jul 18, 201740001179110-17-010441
Jul 13, 201740001179110-17-010365
Jul 11, 201730001104659-17-044504
Jul 7, 201740001179110-17-010236
Jul 5, 201740001104659-17-043682
Jun 28, 20173/A0001104659-17-042159
Jun 28, 201740001104659-17-041909
Jun 27, 201740001104659-17-041903
Jun 27, 201740001104659-17-041905
Jun 27, 201730001104659-17-041834
Jun 27, 201740001104659-17-041899
Jun 27, 201740001104659-17-041904
Jun 27, 201740001104659-17-041902
Jun 27, 2017SC TO-T/A0001104659-17-041853
Jun 27, 201740001104659-17-041898
Jun 27, 201740001104659-17-041907
Jun 27, 201740001104659-17-041901
Jun 27, 201740001104659-17-041906
Jun 26, 20178-K12B0001104659-17-041399
Jun 9, 2017SC TO-T/A0001104659-17-038440
Jun 9, 20174250001104659-17-038432
May 23, 2017424B20001047469-17-003553
May 23, 2017SC TO-T0001047469-17-003554